Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats earnings expectations. Reported EPS is ...
Revenue Guidance -- Management reiterated full-year fiscal 2025 revenue guidance of $26 million to $30 million and set Q4 ...
Bionano Genomics, Inc. ( BNGO) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call. Today's conference is being ...
A new technology may allow patients to recover vision for conditions that were previously thought irreversible ...
The LATAM laboratory equipment and disposables market experienced significant growth in recent years, with a valuation of $1,759 million in 2019. Projections indicate a promising trajectory, with ...
A single microarray can provide information on the expression of tens of thousands of genes. The amount of information generated by a microarray-based experiment is sufficiently large that no single ...
By procedure type, the preimplantation genetic testing market is divided by procedure type into preimplantation genetic ...
OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS PanelEnables ultra-low variant detection across a range of key MRD targets in AML, including very large FLT3-ITDsOxford, UK ...
This study provides a valuable genome-centric characterization of microbial communities across deep sediment cores from a Spartina patens salt marsh. The study provides claims on the metabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results